Mikhail Chernov

Mikhail Chernov

Auto-generated profile, based on publicly available information

Mikhail Chernov

Department of Neurosurgery, Tokyo Women's Medical University Adachi Medical Center, Tokyo, Japan

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2016 in Neurologia medico-chirurgica
Verified
Journal Article
Open access
PDF file
AHAyako Horiba
Ayako Horiba
MHMotohiro Hayashi
Motohiro Hayashi
MCMikhail Chernov
Mikhail Chernov
TKTakakazu Kawamata
Takakazu Kawamata
YOYoshikazu Okada
Yoshikazu Okada
The objective of the retrospective study was to evaluate the factors associated with hearing preservation after low-dose Gamma Knife radiosurgery (GKS) of vestibular schwannomas performed according to the modern standards. From January 2005 to September 2010, 141 consecutive patients underwent such treatment in Tokyo Women’s Medical University. Mean marginal dose was 11.9 Gy (range, 11–12 Gy). The doses for the brain stem, cranial nerves (V, VII, and VIII), and cochlea were kept below 14 Gy, 12 Gy, and 4 Gy, respectively. Out of the total cohort, 102 cases with at least 24 months follow-up were analyzed. Within the median follow-up of 56 months (range, 24–99 months) the crude tumor growth control was 92% (94 cases), whereas its actuarial rate at 5 years was 93%. Out of 49 patients with serviceable hearing on the side of the tumor before GKS, 28 (57%) demonstrated its preservation at the time of the last follow-up. No one evaluated factor, namely Gardner-Robertson hearing class before irradiation, Koos tumor stage, extension of the intrameatal part of the neoplasm up to fundus, nerve of tumor origin, presence of cystic changes in the neoplasm, and cochlea dose demonstrated statistically significant association with preservation of the serviceable hearing after radiosurgery. In conclusion, GKS of vestibular schwannomas performed according to the modern standards of treatment permits to preserve serviceable hearing on the side of the tumor in more than half of the patients. The actual causes of hearing deterioration after radiosurgery remain unclear.

19 December 2014 in Neurosurgical Review
Verified
Journal Article
Closed access
PDF file
SLSamuel M. Lipski
Samuel M. Lipski
MHMotohiro Hayashi
Motohiro Hayashi
MCMikhail Chernov
Mikhail Chernov
MLMarc Levivier
Marc Levivier
YOYoshikazu Okada
Yoshikazu Okada

1 September 2009 in Journal of the Neurological Sciences
Verified
Journal Article
Closed access
MCMikhail F. Chernov
Mikhail F. Chernov
KNKotaro Nakaya
Kotaro Nakaya
HKHidetoshi Kasuya
Hidetoshi Kasuya
Koichi KatoKoichi Kato
Koichi Kato
YOYuko Ono
Yuko Ono
KTKintomo Takakura
Kintomo Takakura

1 January 2021 in Clinical Neurology and Neurosurgery
Verified
Journal Article
Closed access
YKYoshichika Kikuta
Yoshichika Kikuta
YKYuichi Kubota
Yuichi Kubota
HNHidetoshi Nakamoto
Hidetoshi Nakamoto
MCMikhail Chernov
Mikhail Chernov
TKTakakazu Kawamata
Takakazu Kawamata

8 May 2023 in Clinical Neurology and Neurosurgery
Verified
Journal Article
Closed access
HOHidenori Ohbuchi
Hidenori Ohbuchi
HKHidetoshi Kasuya
Hidetoshi Kasuya
SHShinji Hagiwara
Shinji Hagiwara
RKRyuzaburo Kanazawa
Ryuzaburo Kanazawa
SYSuguru Yokosako
Suguru Yokosako
YKYuichi Kubota
Yuichi Kubota

25 July 2023 in Journal of Clinical Neuroscience
Verified
Journal Article
Closed access
RMRaisul Maarif
Raisul Maarif
YKYuichi Kubota
Yuichi Kubota
MCMikhail F. Chernov
Mikhail F. Chernov